Antibiotic Treatment of Adults With Sore Throat by Community Primary Care Physicians: A National Survey, 1989-1999 | Infectious Diseases | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.238.77. Please contact the publisher to request reinstatement.
1.
Woodwell DA. National Ambulatory Medical Care Survey: 1998 Summary. Hyattsville, Md: National Center for Health Statistics; 2000. Advance Data From Vital and Health Statistics, No. 315.
2.
Gwaltney Jr JM, Bisno AL. Pharyngitis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, Pa: Churchill Livingtone; 2000:656-662.
3.
McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat.  CMAJ.1998;158:75-83.Google Scholar
4.
McIsaac WJ, Goel V, To T, Low DE. The validity of a sore throat score in family practice.  CMAJ.2000;163:811-815.Google Scholar
5.
Komaroff AL, Pass TM, Aronson MD.  et al.  The prediction of streptococcal pharyngitis in adults.  J Gen Intern Med.1986;1:1-7.Google Scholar
6.
Walsh BT, Bookheim WW, Johnson RC, Tompkins RK. Recognition of streptococcal pharyngitis in adults.  Arch Intern Med.1975;135:1493-1497.Google Scholar
7.
Kljakovic M. Sore throat presentation and management in general practice.  N Z Med J.1993;106:381-383.Google Scholar
8.
Kaplan EL, Top Jr FH, Dudding BA, Wannamaker LW. Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child.  J Infect Dis.1971;123:490-501.Google Scholar
9.
Poses RM, Cebul RD, Collins M, Fager SS. The accuracy of experienced physicians' probability estimates for patients with sore throats: implications for decision making.  JAMA.1985;254:925-929.Google Scholar
10.
Bisno AL. Acute pharyngitis.  N Engl J Med.2001;344:205-211.Google Scholar
11.
Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.  JAMA.1997;278:901-904.Google Scholar
12.
Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis.  JAMA.1998;279:875-877.Google Scholar
13.
Bisno AL, Gerber MA, Gwaltney Jr JM, Kaplan EL, Schwartz RH.for the Infectious Diseases Society of America.  Diagnosis and management of group A streptococcal pharyngitis: a practice guideline.  Clin Infect Dis.1997;25:574-583.Google Scholar
14.
Snow V, Mottur-Pilson C, Cooper RJ, Hoffman JR. Principles of appropriate antibiotic use for acute pharyngitis in adults.  Ann Intern Med.2001;134:506-508.Google Scholar
15.
Cooper RJ, Hoffman JR, Bartlett JG.  et al.  Principles of appropriate antibiotic use for acute pharyngitis in adults: background.  Ann Intern Med.2001;134:509-517.Google Scholar
16.
Schappert SM. National Ambulatory Medical Care Survey: 1989 summary. National Center for Health Statistics.  Vital Health Stat 13.1992;(110):1-80.Google Scholar
17.
National Center for Health Statistics.  Public use micro-data file documentation, National Ambulatory Medical Care Survey, 1999: machine readable data and documentation produced by the National Center for Health Statistics. Hyattsville, Md: National Technical Information Service; Springfield, Va: US Dept of Commerce; 1999.
18.
Food and Drug Administration.  National Drug Code Directory, 1995 Edition. Washington, DC: Public Health Service; 1995.
19.
Potthoff RF, Woodbury MA, Manton KG. "Equivalent sample size" and "equivalent degrees of freedom" refinements for inference using survey weights under superpopulation models.  J Am Stat Assoc.1992;87:383-396.Google Scholar
20.
Pasko T, Seidman B, Birkhead S. Physician Characteristics and Distribution in the US: 2000-2001 Edition. Chicago, Ill: American Medical Association, Department of Physician Practice and Communications Information, Division of Survey and Data Resources; 2000.
21.
Hooton TM. A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis.  Am J Med.1991;91(3A):23S-26S.Google Scholar
22.
Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity.  Pediatr Infect Dis J.1991;10:275-281.Google Scholar
23.
 Drug Topics Red Book . 103rd ed. Montvale, NJ: Medical Economics Data; 1999.
24.
Boos M, Mayer S, Fischer A.  et al.  In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus Antimicrob Agents Chemother.2001;45:938-942.Google Scholar
25.
Betriu C, Casado MC, Gomez M, Sanchez A, Palau ML, Picazo JJ. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study.  Diagn Microbiol Infect Dis.1999;33:255-260.Google Scholar
26.
Kaplan EL, Johnson DR, Del Rosario MC, Horn DL. Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997.  Pediatr Infect Dis J.1999;18:1069-1072.Google Scholar
27.
Seppala H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci.  Clin Infect Dis.1995;21:1378-1385.Google Scholar
28.
Seppala H, Klaukka T, Vuopio-Varkila J.  et al. for the Finnish Study Group for Antimicrobial Resistance.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland.  N Engl J Med.1997;337:441-446.Google Scholar
29.
York MK, Gibbs L, Perdreau-Remington F, Brooks GF. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California.  J Clin Microbiol.1999;37:1727-1731.Google Scholar
30.
Macris MH, Hartman N, Murray B.  et al.  Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades.  Pediatr Infect Dis J.1998;17:377-381.Google Scholar
31.
Zwart S, Sachs AP, Ruijs GJ, Gubbels JW, Hoes AW, de Melker RA. Penicillin for acute sore throat: randomised double blind trial of seven days versus three days treatment or placebo in adults.  BMJ.2000;320:150-154.Google Scholar
32.
Denny FW, Wannamaker LW, Brink WR, Rammelkamp CH, Custer EA. Prevention of rheumatic fever: treatment of the preceding streptococcal infection.  JAMA.1950;143:151-153.Google Scholar
33.
Wannamaker LW, Rammelkamp CHJ, Denny FW.  et al.  Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcic infection with various amounts of depot penicillin.  Am J Med.1951;10:673-695.Google Scholar
34.
Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat [Cochrane Review]. In: The Cochrane Library. Issue 1, 2001. Oxford, England: Update Software.
Original Contribution
September 12, 2001

Antibiotic Treatment of Adults With Sore Throat by Community Primary Care Physicians: A National Survey, 1989-1999

Author Affiliations

Author Affiliations: General Medicine Division, Massachusetts General Hospital, Boston (Dr Linder); and Stanford Center for Research in Disease Prevention, Palo Alto, Calif (Dr Stafford).

JAMA. 2001;286(10):1181-1186. doi:10.1001/jama.286.10.1181
Abstract

Context Most sore throats are due to viral upper respiratory tract infections. Group A β-hemolytic streptococci (GABHS), the only common cause of sore throat warranting antibiotics, is cultured in 5% to 17% of adults with sore throat. The frequency of antibiotic use for pharyngitis has greatly exceeded the prevalence of GABHS, but less is known about specific classes of antibiotics used. Only penicillin and erythromycin are recommended as first-line antibiotics against GABHS.

Objectives To measure trends in antibiotic use for adults with sore throat and to determine predictors of antibiotic use and nonrecommended antibiotic use.

Design, Setting, and Subjects Retrospective analysis of 2244 visits to primary care physicians in office-based practices in the National Ambulatory Medical Care Survey, 1989-1999, by adults with a chief complaint of sore throat.

Main Outcome Measures Treatment with antibiotics and treatment with nonrecommended antibiotics, extrapolated to US annual national rates.

Results There were an estimated 6.7 million annual visits in the United States by adults with sore throat between 1989 and 1999. Antibiotics were used in 73% (95% confidence interval [CI], 70%-76%) of visits. Patients treated with antibiotics were given nonrecommended antibiotics in 68% (95% CI, 64%-72%) of visits. From 1989 to 1999, there was a significant decrease in use of penicillin and erythromycin and an increase in use of nonrecommended antibiotics, especially extended-spectrum macrolides and extended-spectrum fluoroquinolones (P<.001 for all trends). In multivariable modeling, increasing patient age (odds ratio [OR], 0.86 per decade; 95% CI, 0.79-0.94) and general practice specialty (OR, 1.54 compared with family practice specialty; 95% CI, 1.10-2.14) were independent predictors of antibiotic use. Among patients receiving antibiotics, nonrecommended antibiotic use became more frequent over time (OR, 1.17 per year; 95% CI, 1.11-1.24).

Conclusions More than half of adults are treated with antibiotics for sore throat by community primary care physicians. Use of nonrecommended, more expensive, broader-spectrum antibiotics is frequent.

×